NEW! What Causes Parkinson's Disease?

July 13, 2010

In the first of a two part series on the possible causes of PD, Dave Iverson talks to Dr. William Langston of the Parkinson's Institute about the current state of research in this area, with a special focus on envirnomental risk factors.

Building the Case for a PD Drug Target

July 08, 2010

Brian Fiske, PhD, associate director of research programs at MJFF, discusses the role of the Foundation's Target Validation program in advancing promising ideas through the early stages of PD drug development.

A Multidisciplinary Approach to PD Science

June 22, 2010

Dave Iverson talks to Andy Grove, co-founder of Intel and senior advisor to MJFF about the need for a multidisciplinary approach to developing therapies using neurotrophic factors.

Prioritizing Parkinson's Research

June 01, 2010

MJFF's Vice President of Research Programs Todd Sherer and Dave Iverson discuss MJFF's strategy for prioritizing PD research.

The Impact of Depression on PD

May 18, 2010

Irene Hegeman Richard, MD, of the University of Rochester School of Medicine and Dentistry, discusses the impact of depression on people living with Parkinson's.

Accelerating PD Research

May 04, 2010

MJFF CEO Katie Hood talks to KQED's David Iverson about the Foundation's unique role in the PD research field and upcoming MJFF initiatives.

Biomarkers and PD

April 21, 2010

Ken Marek, MD, of the Institute for Neurodegenerative Disorders talks biomarkers with David Iverson.